As we approach the performance of the first human tiral, the shareprice for AHZ will steadly grow I think based purely on hype. Once the first human trial is completed safely, I would not be surprised to see a new market cap of around $400M.
AHZ already has the largest series ever of patients (500) who have undergone implant surgery (using CardioCel) for congenital heart defects. And they have published the data in one of the leading cardiothoracic surgery journals showing the results here.
Just need to demonstrate the new method of deployment (TAVR) is safe. Obesisty is linked to congenital heart defects and ahving just got back from the USA - I can tell you - everyone is FAT.
Leading Global TAVR Expert Says ADAPT is a GAME CHANGER!, page-6
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.23 |
Change
0.030(0.29%) |
Mkt cap ! $221.9M | |||
| Open | High | Low | Value | Volume |
| $10.50 | $10.50 | $10.06 | $47.74K | 4.652K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3 | $10.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.42 | 899 | 2 |
View Market Depth
| Last trade - 13.27pm 04/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |